Sun Pharm Drug Patent Portfolio

Sun Pharm's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sun Pharm News

Forecast and Size of the U.S. Generic Pharmaceuticals Market from 2025 to 2033 | Longevity

15 Dec, 2025

Semaglutide Patent Dispute: Following Dr. Reddy's Setback, Novo Nordisk Takes Legal Action Against Sun Pharma in Delhi High Court

09 Dec, 2025

Novo Nordisk seeks to prevent Sun Pharma from selling semaglutide, returns to Delhi High Court.

09 Dec, 2025

Could legal issues in the US impact the growth of India's obesity medication market? - Mint

17 Sep, 2025

See More